In this study, mutations of ALAS2, SLC25A38, mitochondria DNA, and PUS1, were identified in 37, 15, 2.5, and 2.5 % of CSA cases, respectively. The gene discussed is ALAS2; the disease is chromosome-type aberration frequency.